Related references
Note: Only part of the references are listed.miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells
Ming Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
Trupti Paranjape et al.
LANCET ONCOLOGY (2011)
A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma
S. E. Godshalk et al.
ONCOGENE (2011)
High-throughput miRNA profiling of human melanoma blood samples
Petra Leidinger et al.
BMC CANCER (2010)
A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Elena Ratner et al.
CANCER RESEARCH (2010)
Signatures of MicroRNAs and Selected MicroRNA Target Genes in Human Melanoma
Demetra Philippidou et al.
CANCER RESEARCH (2010)
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Miguel F. Segura et al.
CLINICAL CANCER RESEARCH (2010)
MicroRNA binding site polymorphisms as biomarkers of cancer risk
Cory Pelletier et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells
Carolina Tarantino et al.
FASEB JOURNAL (2010)
MicroRNA-204/211 alters epithelial physiology
Fei E. Wang et al.
FASEB JOURNAL (2010)
Cross talk between microRNA and epigenetic regulation in adult neurogenesis
Keith E. Szulwach et al.
JOURNAL OF CELL BIOLOGY (2010)
MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
Stefano Caramuta et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Ruth Halaban et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Characterization of the Melanoma miRNAome by Deep Sequencing
Mitchell S. Stark et al.
PLOS ONE (2010)
miR-148 Regulates Mitf in Melanoma Cells
Benedikta S. Haflidadottir et al.
PLOS ONE (2010)
Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F. Graziano et al.
PHARMACOGENOMICS JOURNAL (2010)
MicroRNA miR-137 Regulates Neuronal Maturation by Targeting Ubiquitin Ligase Mind Bomb-1
Richard D. Smrt et al.
STEM CELLS (2010)
Genetic variation in microRNA networks: the implications for cancer research
Brid M. Ryan et al.
NATURE REVIEWS CANCER (2010)
A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers
Brock C. Christensen et al.
CARCINOGENESIS (2009)
miRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma
Daniel W. Mueller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications
Ruth Halaban et al.
PLOS ONE (2009)
MicroRNA-34a Inhibits Uveal Melanoma Cell Proliferation and Migration through Downregulation of c-Met
Dongsheng Yan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
Joachim Silber et al.
BMC MEDICINE (2008)
MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines
Lynne T. Bemis et al.
CANCER RESEARCH (2008)
A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non-Small Cell Lung Cancer Risk
Lena J. Chin et al.
CANCER RESEARCH (2008)
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer
Ken-ichi Kozaki et al.
CANCER RESEARCH (2008)
miRNA modulation of the cellular stress response
Imran A. Babar et al.
FUTURE ONCOLOGY (2008)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies
Gerald Saldanha et al.
CLINICAL CANCER RESEARCH (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
Vikas K. Goel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Pathology of malignant melanoma
V Liu et al.
SURGICAL CLINICS OF NORTH AMERICA (2003)
Share Paper
